Related Experiment Video
Updated: May 2, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Making human derived data FAIR: feedback from NCI office of data sharing workshop
Mousumi Ghosh1, Ying Huang1, Heather K Basehore1
1Office of Data Sharing, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Federal policies promote sharing biomedical research data responsibly. Workshops identified essential patient clinical data for cancer research, aiming for FAIR data principles to maximize research impact.
Area of Science:
- Biomedical research
- Data science
- Cancer research
Background:
- US federal policies, including NIH Data Management and Sharing (DMS) and Public Access Policies, mandate responsible sharing of publicly funded research outputs.
- Ensuring scientific data is FAIR (findable, accessible, interoperable, reusable) is crucial for maximizing its usability and impact.
- The National Cancer Institute (NCI) Office of Data Sharing (ODS) convened workshops to address clinical data sharing challenges.
Purpose of the Study:
- To identify high-value clinical data features for collection and sharing in cancer research.
- To explore data use challenges and propose solutions for effective scientific data sharing.
- To establish consensus on minimum patient-derived clinical information for comprehensive cancer research.
Main Methods:
- Conducted a series of workshops involving researchers and stakeholders.
- Summarized workshop discussions on data use challenges and potential solutions.
- Identified consensus on essential patient-derived clinical data for cancer research.
Main Results:
- Highlighted the need for structured outputs for various data types and methodologies to enable FAIR sharing.
- Outlined attendee consensus on minimum patient-derived clinical information required for diverse cancer research.
- Identified data use challenges and proposed potential solutions for effective data sharing.
Conclusions:
- Workshop outputs provide a foundation for best practice recommendations on collecting and sharing impactful clinical data.
- Proposed preliminary guidance for policymakers and researchers on consistent and effective management of human-derived clinical data.
- Emphasized the importance of FAIR data principles for enhancing the sharing process and outcomes for data end-users in cancer research.
More Related Videos
04:07Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
Related Concept Videos
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
Evolutionary Relationships through Genome Comparisons
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
DNA Microarrays
Bias in Epidemiological Studies
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...